184 related articles for article (PubMed ID: 12208106)
1. Proliferation activity in oral and cutaneous canine melanocytic tumours: correlation with histological parameters, location, and clinical behaviour.
Millanta F; Fratini F; Corazza M; Castagnaro M; Zappulli V; Poli A
Res Vet Sci; 2002 Aug; 73(1):45-51. PubMed ID: 12208106
[TBL] [Abstract][Full Text] [Related]
2. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs.
Roels S; Tilmant K; Ducatelle R
J Comp Pathol; 1999 Jul; 121(1):13-24. PubMed ID: 10373290
[TBL] [Abstract][Full Text] [Related]
3. Lack of prognostic significance of angiogenesis in canine melanocytic tumours.
Cuitiño MC; Massone AR; Idiart JR
J Comp Pathol; 2012; 147(2-3):147-52. PubMed ID: 22520819
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 expression is related with localization, proliferation, and overall survival in canine melanocytic neoplasms.
Martínez CM; Peñafiel-Verdú C; Vilafranca M; Ramírez G; Méndez-Gallego M; Buendía AJ; Sánchez J
Vet Pathol; 2011 Nov; 48(6):1204-11. PubMed ID: 21292918
[TBL] [Abstract][Full Text] [Related]
5. COX-1 and COX-2 expression in canine cutaneous, oral and ocular melanocytic tumours.
Pires I; Garcia A; Prada J; Queiroga FL
J Comp Pathol; 2010; 143(2-3):142-9. PubMed ID: 20207364
[TBL] [Abstract][Full Text] [Related]
6. Prognosis after surgical excision of canine melanomas.
Bostock DE
Vet Pathol; 1979 Jan; 16(1):32-40. PubMed ID: 462717
[TBL] [Abstract][Full Text] [Related]
7. E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis.
Silvestri S; Porcellato I; Mechelli L; Menchetti L; Iussich S; De Maria R; Sforna M; Bongiovanni L; Brachelente C
Vet Pathol; 2020 Sep; 57(5):608-619. PubMed ID: 32578507
[TBL] [Abstract][Full Text] [Related]
8. [Developmental studies on melanoma of the skin and mouth mucosa of dogs].
Frese K
Vet Pathol; 1978 Jul; 15(4):461-73. PubMed ID: 695220
[TBL] [Abstract][Full Text] [Related]
9. MIB-1 immunoreactivity correlates with biologic behaviour in canine cutaneous melanoma.
Laprie C; Abadie J; Amardeilh MF; Net JL; Lagadic M; Delverdier M
Vet Dermatol; 2001 Jun; 12(3):139-47. PubMed ID: 11420929
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Ki-67 expression in feline non-ocular melanocytic tumours.
Sabattini S; Renzi A; Albanese F; Fantinati M; Rigillo A; Abramo F; Tornago R; Tortorella G; Massaro M; Pagano TB; Buchholz J; Bettini G
BMC Vet Res; 2018 Oct; 14(1):309. PubMed ID: 30314485
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas.
Silveira TL; Veloso ES; Gonçalves INN; Costa RF; Rodrigues MA; Cassali GD; Del Puerto HL; Pang LY; Argyle DJ; Ferreira E
Vet Comp Oncol; 2020 Dec; 18(4):727-738. PubMed ID: 32323423
[TBL] [Abstract][Full Text] [Related]
12. Canine balloon and signet-ring cell melanomas: a histological and immunohistochemical characterization.
Cangul IT; van Garderen E; van der Linde-Sipman JS; van den Ingh TS; Schalken JA
J Comp Pathol; 2001; 125(2-3):166-73. PubMed ID: 11578133
[TBL] [Abstract][Full Text] [Related]
13. C-kit expression in canine mucosal melanomas.
Newman SJ; Jankovsky JM; Rohrbach BW; LeBlanc AK
Vet Pathol; 2012 Sep; 49(5):760-5. PubMed ID: 21825314
[TBL] [Abstract][Full Text] [Related]
14. Tumor Thickness and Modified Clark Level in Canine Cutaneous Melanocytic Tumors.
Silvestri S; Porcellato I; Mechelli L; Menchetti L; Rapastella S; Brachelente C
Vet Pathol; 2019 Mar; 56(2):180-188. PubMed ID: 30244658
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of MDR1-Pgp 170 in canine cutaneous and oral melanomas: pattern of expression and association with tumour location and phenotype.
Finotello R; Monné Rodriguez JM; Vilafranca M; Altimira J; Ramirez GA; Haines A; Ressel L
Vet Comp Oncol; 2017 Dec; 15(4):1393-1402. PubMed ID: 27779366
[TBL] [Abstract][Full Text] [Related]
16. Canine cutaneous melanocytic tumours: significance of β-catenin and survivin immunohistochemical expression.
Bongiovanni L; D'Andrea A; Porcellato I; Ciccarelli A; Malatesta D; Romanucci M; Della Salda L; Mechelli L; Brachelente C
Vet Dermatol; 2015 Aug; 26(4):270-e59. PubMed ID: 25962968
[TBL] [Abstract][Full Text] [Related]
17. Mast cells and angiogenesis in canine melanomas: malignancy and clinicopathological factors.
Mukaratirwa S; Chikafa L; Dliwayo R; Moyo N
Vet Dermatol; 2006 Apr; 17(2):141-6. PubMed ID: 16515657
[TBL] [Abstract][Full Text] [Related]
18. Fascin-1 expression in canine cutaneous and oral melanocytic tumours.
Yamada N; Mori T; Murakami M; Noguchi S; Sakai H; Akao Y; Maruo K
Vet Comp Oncol; 2012 Dec; 10(4):303-11. PubMed ID: 22236355
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of tenascin in melanocytic tumours of dogs.
Sevastre B; van Ederen AM; Terlou M; Gruys E; Nederbragt H
J Comp Pathol; 2007 Jan; 136(1):49-56. PubMed ID: 17258226
[TBL] [Abstract][Full Text] [Related]
20. MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas.
Ramsay JA; From L; Iscoe NA; Kahn HJ
J Invest Dermatol; 1995 Jul; 105(1):22-6. PubMed ID: 7615970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
